Search

Your search keyword '"Medical laboratories"' showing total 79 results
Start Over Descriptor "Medical laboratories" Publication Year Range This year
79 results on '"Medical laboratories"'

1. Martin C. Mihm, Jr. and Dermatopathology Education at Harvard Medical School.

Author

Duncan, Lyn M., Tahan, Steven R., Hoang, Mai P., and Murphy, George F.

Subjects
*VETERANS' hospitals, *MEDICAL school curriculum, *WOMEN'S hospitals, *PEDIATRIC clinics, *MEDICAL education, *MEDICAL laboratories, *ACADEMIC medical centers
Abstract

The article discusses the evolution of dermatopathology education at Harvard Medical School, particularly focusing on the contributions of Dr. Martin C. Mihm, Jr. The program was established in 1975 and has since expanded to two training programs at different Harvard-affiliated institutions. Graduates have excelled in various fields, including academia, research, and commercial enterprises. The legacy of Dr. Mihm continues to inspire excellence in teaching, investigation, and patient care within the field of dermatopathology. [Extracted from the article]

Published
2025
Full Text
View/download PDF

2. EN ISO 15189 revision: EFLM Committee Accreditation and ISO/CEN standards (C: A/ISO) analysis and general remarks on the changes.

Author

Linko, Solveig, Boursier, Guilaine, Bernabeu-Andreu, Francisco A., Dzneladze, Nana, Vanstapel, Florent, Brguljan, Pika Meško, Tosheska-Trajkovska, Katerina, Mehay, Hélène, Panteghini, Mauro, Brugnoni, Duilio, Milinkovic, Neda, Lohmander, Maria, Šprongl, Luděk, Çubukçu, Hikmet Can, and Thelen, Marc

Subjects
*COMMUNITY health services, *MEDICAL laws, *CLINICAL pathology, *PATIENT safety, *ACCREDITATION, *MEDICAL laboratories, *HOSPITAL accreditation
Abstract

The EN ISO 15189:2022 standard, titled “Medical laboratories – Requirements for quality and competence,” is a significant update to the regulations for medical laboratories. The revised standard was published on December 6, 2022, replacing both EN ISO 15189:2012 and EN ISO 22870:2016. Key objectives of the revision include: 1. Alignment with ISO/IEC 17025:2017, 2. Removal of unintended prescription, 3. Focus on patient interest and safety, 4. Minimization of new requirements, and 5. Improved clarity of text. Dedicating to harmonizing accreditation processes across Europe the EFLM Committee on Accreditation and ISO/CEN standards (C: A/ISO) has produced this guidance document to assist the laboratory medicine community in understanding and implementing the criteria of the EN ISO 15189 revision. Two main objectives of the guidance in educating both laboratories and accreditation bodies with their assessors as well as other stakeholders in laboratory medicine were agreed on. Firstly, to clarify the relevant changes covering all paragraphs of the standard and secondly to make an impact analysis on previous C: A/ISO guidance documents. [ABSTRACT FROM AUTHOR]

Published
2025
Full Text
View/download PDF

3. Behind the scenes of EQA–characteristics, capabilities, benefits and assets of external quality assessment (EQA)

Author

Buchta, Christoph, De la Salle, Barbara, Marrington, Rachel, Albarède, Stéphanie, Badrick, Tony, Bicker, Wolfgang, Bietenbeck, Andreas, Bullock, David, Delatour, Vincent, Dequeker, Elisabeth, Flasch, Mira, Geilenkeuser, Wolf-Jochen, van Hellemond, Jaap, Huggett, Jim F., Ianovska, Viktoriia, Kaiser, Patricia, Kammel, Martin, Kessler, Anja, Laudus, Nele, and Luppa, Peter B.

Subjects
*MOLECULAR pathology, *PATHOLOGICAL laboratories, *MEDICAL equipment, *PATIENT care, *METROLOGY, *MEDICAL laboratories
Abstract

The main stakeholders in external quality assessment (EQA) programs are the participants, in whose interests these challenges are ultimately organised. EQA schemes in the medical field contribute to improving the quality of patient care by evaluating the analytical and diagnostic quality of laboratory and point-of-care tests (POCT) by independent third parties and, if necessary, pointing out erroneous measurement results and analytical or diagnostic improvement potential. Other benefits include the option of using EQA samples for other important laboratory procedures, such as the verification or validation of in vitro diagnostic medical devices (IVD-MDs), a contribution to the estimation of measurement uncertainty, a means of training and educating laboratory staff through educational EQA programmes or samples, or even for independent and documented monitoring of staff competence, such as on samples with unusual or even exceptional characteristics. Participation in an EQA scheme for beneficiaries like medical, microbiological and histo- and molecular pathology laboratories, users of POCT and self-testing systems as well as National Metrology Institutes, calibration laboratories and reference laboratories that are dedicated to specific tasks and have particular expectations of the EQA scheme are presented here. [ABSTRACT FROM AUTHOR]

Published
2025
Full Text
View/download PDF

4. Direct-to-consumer testing as consumer initiated testing: compromises to the testing process and opportunities for quality improvement: An opinion paper from the EFLM DTCT-Taskforce.

Author

Shih, Patti, Sandberg, Sverre, Balla, Jan, Basok, Banu Isbilen, Brady, Jennifer J., Croal, Bernard, De Vos, Nathalie, Karlsson, Mathias, Kedars, Piret, Ozben, Tomris, Pijanovic, Marina, Plebani, Mario, and Orth, Matthias

Subjects
*CONFORMANCE testing, *CONSUMERS, *MEDICAL personnel, *DIRECT selling, *LAYPERSONS, *MEDICAL laboratories
Abstract

Direct-to-consumer testing (DTCT) refers to commercial laboratory tests initiated by laypersons without the involvement of healthcare professionals. As this market grows in size and variety of products, a clear definition of DTCT to ground the conceptualization of their harms and benefits is needed. We describe how three different modalities of DTCT (home self-testing, self-sampled tests, and direct access tests) present caveats to the traditional testing process ('brain-to-brain loop'), and how this might differ between medical vs. non-medical laboratories. We make recommendations for ways to improve quality and reduce errors with respect to DTCT. The potential benefits and harms of DTCT will invariably depend on the context and situation of individual consumers and the types of tests involved. Importantly, implications for both consumers and the healthcare system should be considered, such as the effects on improving health outcomes and reducing unnecessary testing and use of clinical resources. 'Consumer initiation' must be a central defining characteristic of DTCT, to clearly demarcate the key drawbacks as well as opportunities of this type of testing from a laboratory specialists' perspective. The concept of 'consumer initiated testing' should also help define DTCT regulation, and provide a locus of efforts to support consumers as the main decision-makers in the purchasing and conducting of these tests in the absence of clinician gatekeeping. [ABSTRACT FROM AUTHOR]

Published
2025
Full Text
View/download PDF

5. Comment on Lippi et al.: EFLM Task Force Preparation of Labs for Emergencies (TF-PLE) recommendations for reinforcing cyber-security and managing cyber-attacks in medical laboratories.

Author

Lapić, Ivana, Rogić, Dunja, Fuček, Mirjana, and Alpeza Viman, Ines

Subjects
*INBORN errors of metabolism, *INFORMATION technology, *BLOOD cell count, *BLOOD sedimentation, *MEDICAL laboratories, *RANSOMWARE
Abstract

The document discusses the impact of a ransomware cyber-attack on the University Hospital Centre Zagreb in Croatia, which resulted in the shutdown of all hospital IT systems, including laboratory services. The laboratory staff had to quickly implement emergency protocols to ensure uninterrupted service, such as accepting handwritten requests and prioritizing critical samples. It took over a month to fully recover from the cyber-attack, prompting the institution to enhance its emergency response protocols and cyber-security measures. The experience serves as a reminder of the importance of preparedness planning and cyber-security in medical laboratories. [Extracted from the article]

Published
2025
Full Text
View/download PDF

6. Studies from Medical Laboratory Technology in the Area of Thrombocytopenia Published (Prevalence of thrombocytopenia in patients with viral infection across different cities in India)

Subjects
Antiviral agents, Infection -- Care and treatment, Physical fitness, Medical laboratories, Thrombocytopenia -- Care and treatment, Health
Abstract

2025 JAN 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on thrombocytopenia have been presented. According to news originating from [...]

Published
2025

8. CRL Diagnostics Announces the take over of CPL Noida

Subjects
Diagnostic equipment (Medical), Medical laboratories, Health
Abstract

CRL Diagnostics, a leading provider of diagnostic services, is pleased to announce the official takeover of CPL Noida to CRL Diagnostics, effective January 1, 2025. This strategic move reflects the [...]

Published
2025

10. Have you heard about the (other) major regulatory change this year? CLIA changed its proficiency testing criteria -- and almost no one is talking about it.

Author

Westgard, Sten

Subjects
*CONTINUING education units, *GLYCOSYLATED hemoglobin, *MEDICAL quality control, *GOAL (Psychology), *CLINICAL pathology, *PATHOLOGICAL laboratories, *PATHOLOGICAL laboratory laws, *MEDICAL laboratories, *QUALITY assurance, *GOVERNMENT regulation, *RULES
Abstract

The article reports on the regulatory reform of the Clinical Laboratory Improvement Amendments (CLIA) of 1988 statute relating to proficiency testing (PT) criteria. Topics mentioned include the reason why the PT criteria are amended, the Six Sigma approach to predict failure in PT, the different kinds of changes in PT criteria and the impact of CLIA PT rules.

Published
2025

12. UAE Clinical Laboratory Services Market: Growth Driven by Advancements and Strategic Investments, Projected to Reach $2.5 Billion by 2034 - Transparency Market Research, Inc

Subjects
Marketing research, Medical laboratories, Investments -- Market research -- Market size, Company growth, Marketing research, General interest, News, opinion and commentary
Abstract

Wilmington, Delaware: Transparency Market Research has issued the following news release: The UAE clinical laboratory services industry (Sn`@ khdmt lmkhtbrt lsryry@ ) has witnessed remarkable growth, with the market valued [...]

Published
2025

13. Cellworks' Computational Biosimulation Lab Secures CLIA Certification to Advance Personalized Therapy Decision Support

Subjects
United States. Centers for Medicare and Medicaid Services, Patients -- Care and treatment, Medical laboratories, General interest, News, opinion and commentary
Abstract

SOUTH SAN FRANCISCO: CELLWORKS GROUP, INC. has issued the following news release: Cellworks Group, Inc., a leader in Personalized Therapy Decision Support and Precision Drug Development, today announced that its [...]

Published
2025

14. TriCore Renews Contract with MedSpeed

Subjects
Logistics services, Medical laboratories, Contract agreement, Business, News, opinion and commentary
Abstract

Healthcare logistics company has helped optimize specimen delivery since 2016 ALBUQUERQUE, N.M., Jan. 14, 2025 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=4339633-1&h=616617330&u=https%3A%2F%2Fwww.tricore.org%2Fabout-tricore%2F&a=TriCore, an independent clinical laboratory headquartered in Albuquerque, N.M., has renewed its partnership [...]

Published
2025

16. Applied BioCode Announces New Nucleic Acid Extraction Claim for KingFisher[TM] Flex Nucleic Acid Purification System with BioCode[R] Gastrointestinal Pathogen Panel (GPP)

Subjects
United States. Food and Drug Administration, Nucleic acids, Medical laboratories, Business, Business, international
Abstract

SANTA FE SPRINGS, Calif. -- Applied BioCode, a leader in molecular diagnostics panel testing, is excited to announce a significant enhancement to its BioCode([R]) Gastrointestinal Pathogen Panel (GPP) with the [...]

Published
2025

17. Cellworks' Computational Biosimulation Lab Secures CLIA Certification to Advance Personalized Therapy Decision Support

Subjects
United States. Centers for Medicare and Medicaid Services, Medical laboratories, Business, Business, international
Abstract

CLIA Certification Broadens Cellworks' Capabilities to Deliver Personalized Therapy Predictions that Improve Cancer Treatment Outcomes SOUTH SAN FRANCISCO, Calif. -- Cellworks Group, Inc., a leader in Personalized Therapy Decision Support [...]

Published
2025

20. Euro-Med Laboratories Phil., Inc.: Other SEC Forms, Reports and Requirements (CR00040-2025)

Subjects
Philippine Stock Exchange Inc., Securities industry, Medical laboratories, Securities industry, General interest, News, opinion and commentary
Abstract

Taguig City: Philippine Stock Exchange has issued the following company announcement: Euro-Med Laboratories Phil., Inc. EURO PSE Disclosure Form 17-18 - Other SEC Forms/Reports/Requirements Form/Report Type Board of Directors' Attendance [...]

Published
2025

21. Castle Biosciences Announces New York State Department of Health Approval of Its TissueCypher[R] Barrett's Esophagus Test

Subjects
Administrative agencies, Medical research, Medicine, Experimental, Patients -- Care and treatment, Medical laboratories, Business, Business, international
Abstract

With this approval, all of the tests in Castle's dermatology, gastroenterology and ophthalmology portfolios, as well as its clinical laboratories in Phoenix and Pittsburgh, are now approved by the state [...]

Published
2025

22. Genetic testing could improve treatment for patients with the virulent multidrug-resistant fungus Candida auris

Subjects
Medical research, Medicine, Experimental, Anidulafungin, Fungi, Medical laboratories, Genetic screening, Caspofungin, General interest, News, opinion and commentary
Abstract

WASHINGTON: Association for Diagnostics & Laboratory Medicine (ADLM) has issued the following press release: A new study shows that genetic testing could be used to determine which drugs will -- [...]

Published
2025

23. A collaborative paradigm to improve 21st century healthcare explored in special January issue of ADLM's The Journal of Applied Laboratory Medicine

Subjects
Health care reform, Patients -- Care and treatment, Medical laboratories, General interest, News, opinion and commentary
Abstract

WASHINGTON: Association for Diagnostics & Laboratory Medicine (ADLM) has issued the following press release: Diagnostic stewardship brings together healthcare professionals across specialties to ensure patients get the right clinical laboratory [...]

Published
2025

24. A collaborative paradigm to improve 21st century healthcare explored in special January issue of ADLM's The Journal of Applied Laboratory Medicine

Subjects
Health care reform, Patients -- Care and treatment, Medical laboratories, Business, News, opinion and commentary
Abstract

WASHINGTON, Jan. 3, 2025 /PRNewswire/ -- Diagnostic stewardship brings together healthcare professionals across specialties to ensure patients get the right clinical laboratory tests at the right time. This special issue [...]

Published
2025

35. Data on Health and Medicine Discussed by a Researcher at University Hospital Infanta Sofia (High-Sensitivity Flow Cytometry for the Reliable Detection of Measurable Residual Disease in Hematological Malignancies in Clinical Laboratories)

Subjects
Diseases -- Spain, Medical laboratories, Health
Abstract

2025 JAN 6 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Investigators publish new report on agriculture. According to news reporting originating from Madrid, Spain, by [...]

Published
2025

36. Study Results from Medical Laboratory Science Update Understanding of Military Medicine (Drug resistance in HIV's interaction with reverse transcriptase and integrase strand transfer inhibitors among Nigerians attending a military hospital)

Subjects
HIV (Viruses) -- Drug therapy, Antiviral agents, Drug interactions, Medical laboratories, DNA polymerases, Health
Abstract

2025 JAN 6 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Researchers detail new data in military medicine. According to news reporting from the Medical Laboratory [...]

Published
2025

47. Findings from National University of Lesotho Advance Knowledge in Laboratory Medicine (Healthcare waste management knowledge, attitudes and practices of laboratory workers at a regional hospital, Lesotho)

Subjects
Workers, Biosafety, Refuse and refuse disposal, Medical laboratories, Health, National University of Lesotho
Abstract

2025 JAN 3 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on laboratory medicine have been published. According to news reporting [...]

Published
2025

49. Rubella Serology: A Renewed Call to Action.

Author

Dimech, Wayne

Subjects
*VIRAL antibodies, *MEDICAL protocols, *IMMUNIZATION, *RUBELLA, *SEROLOGY, *GENETIC disorders, *VACCINE hesitancy, *SERODIAGNOSIS, *MEDICAL laboratories, *QUALITY assurance, *BIOLOGICAL assay, *RUBELLA vaccines
Published
2025
Full Text
View/download PDF

50. Natera, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Dec. 26, 2024).

Subjects
PUBLIC companies, INDUSTRY classification, FINANCIAL statements, FILING systems (Documents), MEDICAL laboratories
Abstract

Natera, Inc. filed a Form 4 with the U.S. Securities and Exchange Commission on December 26, 2024. The company's SIC code is 8071, indicating it is in the Medical Laboratories industry. Form 4 is required for directors, officers, or owners of more than ten percent of a class of equity securities to report changes in ownership. This filing is a formal document submitted by publicly-traded companies to the SEC. [Extracted from the article]

Published
2025

Catalog

Books, media, physical & digital resources
See catalog results